213 related articles for article (PubMed ID: 23286920)
1. Ligand-specific binding and activation of the human adenosine A(2B) receptor.
Thimm D; Schiedel AC; Sherbiny FF; Hinz S; Hochheiser K; Bertarelli DC; Maass A; Müller CE
Biochemistry; 2013 Jan; 52(4):726-40. PubMed ID: 23286920
[TBL] [Abstract][Full Text] [Related]
2. The four cysteine residues in the second extracellular loop of the human adenosine A2B receptor: role in ligand binding and receptor function.
Schiedel AC; Hinz S; Thimm D; Sherbiny F; Borrmann T; Maass A; Müller CE
Biochem Pharmacol; 2011 Aug; 82(4):389-99. PubMed ID: 21620804
[TBL] [Abstract][Full Text] [Related]
3. GPCR structure and activation: an essential role for the first extracellular loop in activating the adenosine A2B receptor.
Peeters MC; van Westen GJ; Guo D; Wisse LE; Müller CE; Beukers MW; Ijzerman AP
FASEB J; 2011 Feb; 25(2):632-43. PubMed ID: 21030693
[TBL] [Abstract][Full Text] [Related]
4. The second extracellular loop of GPCRs determines subtype-selectivity and controls efficacy as evidenced by loop exchange study at A2 adenosine receptors.
Seibt BF; Schiedel AC; Thimm D; Hinz S; Sherbiny FF; Müller CE
Biochem Pharmacol; 2013 May; 85(9):1317-29. PubMed ID: 23500543
[TBL] [Abstract][Full Text] [Related]
5. BAY60-6583 acts as a partial agonist at adenosine A2B receptors.
Hinz S; Lacher SK; Seibt BF; Müller CE
J Pharmacol Exp Ther; 2014 Jun; 349(3):427-36. PubMed ID: 24633424
[TBL] [Abstract][Full Text] [Related]
6. New, non-adenosine, high-potency agonists for the human adenosine A2B receptor with an improved selectivity profile compared to the reference agonist N-ethylcarboxamidoadenosine.
Beukers MW; Chang LC; von Frijtag Drabbe Künzel JK; Mulder-Krieger T; Spanjersberg RF; Brussee J; IJzerman AP
J Med Chem; 2004 Jul; 47(15):3707-9. PubMed ID: 15239649
[TBL] [Abstract][Full Text] [Related]
7. Tritium-labeled agonists as tools for studying adenosine A
Hinz S; Alnouri WM; Pleiss U; Müller CE
Purinergic Signal; 2018 Sep; 14(3):223-233. PubMed ID: 29752618
[TBL] [Abstract][Full Text] [Related]
8. Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives as adenosine receptor antagonists. Influence of the N5 substituent on the affinity at the human A 3 and A 2B adenosine receptor subtypes: a molecular modeling investigation.
Pastorin G; Da Ros T; Spalluto G; Deflorian F; Moro S; Cacciari B; Baraldi PG; Gessi S; Varani K; Borea PA
J Med Chem; 2003 Sep; 46(20):4287-96. PubMed ID: 13678407
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors.
Varani K; Gessi S; Merighi S; Vincenzi F; Cattabriga E; Benini A; Klotz KN; Baraldi PG; Tabrizi MA; Lennan SM; Leung E; Borea PA
Biochem Pharmacol; 2005 Nov; 70(11):1601-12. PubMed ID: 16219300
[TBL] [Abstract][Full Text] [Related]
10. Probing biased/partial agonism at the G protein-coupled A(2B) adenosine receptor.
Gao ZG; Balasubramanian R; Kiselev E; Wei Q; Jacobson KA
Biochem Pharmacol; 2014 Aug; 90(3):297-306. PubMed ID: 24853985
[TBL] [Abstract][Full Text] [Related]
11. Expression, pharmacological profile, and functional coupling of A2B receptors in a recombinant system and in peripheral blood cells using a novel selective antagonist radioligand, [3H]MRE 2029-F20.
Gessi S; Varani K; Merighi S; Cattabriga E; Pancaldi C; Szabadkai Y; Rizzuto R; Klotz KN; Leung E; Mac Lennan S; Baraldi PG; Borea PA
Mol Pharmacol; 2005 Jun; 67(6):2137-47. PubMed ID: 15788741
[TBL] [Abstract][Full Text] [Related]
12. Both A2a and A2b adenosine receptors at reperfusion are necessary to reduce infarct size in mouse hearts.
Methner C; Schmidt K; Cohen MV; Downey JM; Krieg T
Am J Physiol Heart Circ Physiol; 2010 Oct; 299(4):H1262-4. PubMed ID: 20709859
[TBL] [Abstract][Full Text] [Related]
13. Novel 1,3-dipropyl-8-(3-benzimidazol-2-yl-methoxy-1-methylpyrazol-5-yl)xanthines as potent and selective A₂B adenosine receptor antagonists.
Baraldi PG; Baraldi S; Saponaro G; Preti D; Romagnoli R; Piccagli L; Cavalli A; Recanatini M; Moorman AR; Zaid AN; Varani K; Borea PA; Tabrizi MA
J Med Chem; 2012 Jan; 55(2):797-811. PubMed ID: 22148859
[TBL] [Abstract][Full Text] [Related]
14. Random mutagenesis of the human adenosine A2B receptor followed by growth selection in yeast. Identification of constitutively active and gain of function mutations.
Beukers MW; van Oppenraaij J; van der Hoorn PP; Blad CC; den Dulk H; Brouwer J; IJzerman AP
Mol Pharmacol; 2004 Mar; 65(3):702-10. PubMed ID: 14978249
[TBL] [Abstract][Full Text] [Related]
15. Human adenosine A(1), A(2A), A(2B), and A(3) receptors expressed in Chinese hamster ovary cells all mediate the phosphorylation of extracellular-regulated kinase 1/2.
Schulte G; Fredholm BB
Mol Pharmacol; 2000 Sep; 58(3):477-82. PubMed ID: 10953039
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists.
Baraldi PG; Tabrizi MA; Preti D; Bovero A; Romagnoli R; Fruttarolo F; Zaid NA; Moorman AR; Varani K; Gessi S; Merighi S; Borea PA
J Med Chem; 2004 Mar; 47(6):1434-47. PubMed ID: 14998332
[TBL] [Abstract][Full Text] [Related]
17. Oxidative/nitrosative stress selectively altered A(2B) adenosine receptors in chronic obstructive pulmonary disease.
Varani K; Caramori G; Vincenzi F; Tosi A; Barczyk A; Contoli M; Casolari P; Triggiani M; Hansel T; Leung E; Maclennan S; Barnes PJ; Chung KF; Adcock I; Papi A; Borea PA
FASEB J; 2010 Apr; 24(4):1192-204. PubMed ID: 20008542
[TBL] [Abstract][Full Text] [Related]
18. Adenosine A₂B receptor agonism inhibits neointimal lesion development after arterial injury in apolipoprotein E-deficient mice.
Bot I; de Vries H; Korporaal SJ; Foks AC; Bot M; van Veldhoven J; Ter Borg MN; van Santbrink PJ; van Berkel TJ; Kuiper J; Ijzerman AP
Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2197-205. PubMed ID: 22743060
[TBL] [Abstract][Full Text] [Related]
19. Site-directed mutagenesis of alpha 2A-adrenergic receptors: identification of amino acids involved in ligand binding and receptor activation by agonists.
Wang CD; Buck MA; Fraser CM
Mol Pharmacol; 1991 Aug; 40(2):168-79. PubMed ID: 1678850
[TBL] [Abstract][Full Text] [Related]
20. Modulation of insulin release by adenosine A1 receptor agonists and antagonists in INS-1 cells: the possible contribution of 86Rb+ efflux and 45Ca2+ uptake.
Töpfer M; Burbiel CE; Müller CE; Knittel J; Verspohl EJ
Cell Biochem Funct; 2008 Dec; 26(8):833-43. PubMed ID: 18979526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
